J0180
HCPCSAgalsidase beta injection
Official HCPCS Level II long descriptor
Injection, agalsidase beta, 1 mg
HCPCS Level II code J0180 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Agalsidase beta injection
Added to HCPCS: 2005-01-01
Nearby codes in J0
- J0167Inj epinephrine (hospira)
- J0168Epinephrine (intl med sys)
- J0169Inj epinephrine (adrenalin)
- J0174Lecanemab-irmb, for iv inj
- J0175Inj, donanemab-azbt, 2 mg
- J0177Inj, aflibercept hd, 1 mg
- J0178Aflibercept injection
- J0179Inj, brolucizumab-dbll, 1 mg
- J0184Inj, amisulpride, 1 mg
- J0185Inj., aprepitant, 1 mg
- J0202Injection, alemtuzumab
- J0206Inj allopurinol sodium 1 mg
- J0207Amifostine
- J0208Inj, pedmark, 100 mg
- J0209Inj, sod thiosulfate (hope)
- J0210Methyldopate hcl injection
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.